Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
NEW YORK--(BUSINESS WIRE)---- $LLY #NYSE--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate
11:36am, Wednesday, 21'st Jan 2026
Eli Lilly wins FDA Breakthrough Therapy status for sofetabart mipitecan in certain patients with platinum-resistant ovarian cancer.
Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement
10:00am, Wednesday, 21'st Jan 2026
INDIANAPOLIS, Jan. 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2025 financial results on February 4, 2026. Lilly will also conduct a conference call t
Eli Lilly: Breakout To New Highs Sends A Clear Warning Shot
09:14am, Wednesday, 21'st Jan 2026
Eli Lilly remains the dominant force in obesity drugs, with strong momentum ahead of its anticipated Q2 oral obesity drug launch. Eli Lilly's oral drug entry is expected to lower barriers for new pati
Dynasty Wealth Management LLC Sells 3,206 Shares of Eli Lilly and Company $LLY
04:43am, Wednesday, 21'st Jan 2026
Dynasty Wealth Management LLC lowered its position in Eli Lilly and Company (NYSE: LLY) by 77.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional inves
Wealth Management Associates, Inc. Buys 5 Shares of Eli Lilly and Co (LLY)
09:08am, Tuesday, 20'th Jan 2026
Summary Wealth Management Associates, Inc. raised its stake in Eli Lilly and Co (LLY) by 0.14%, purchasing 5 shares to own 3,693 shares valued at about
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026
08:29am, Tuesday, 20'th Jan 2026
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk.
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabar
Abivax CEO dismisses 'noise' around rumored Eli Lilly bid
06:01am, Tuesday, 20'th Jan 2026
Abivax Chief Executive Marc de Garidel dismissed as "noise" reports in the French press that pharmaceutical giant Eli Lilly may take over his company, and said market speculation about an ongoing revi
Arkadios Wealth Advisors Increases Stock Position in Eli Lilly and Company $LLY
04:48am, Tuesday, 20'th Jan 2026
Arkadios Wealth Advisors raised its holdings in Eli Lilly and Company (NYSE: LLY) by 21.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever
10:47am, Monday, 19'th Jan 2026
Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie's immunosuppressant portfolio helps it to produce steady revenue and profits.
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan
08:41am, Monday, 19'th Jan 2026
Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.
JCIC Asset Management Inc. Buys New Shares in Eli Lilly and Company $LLY
07:00am, Monday, 19'th Jan 2026
JCIC Asset Management Inc. purchased a new position in Eli Lilly and Company (NYSE: LLY) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)
Formidable Asset Management LLC Increases Stake in Eli Lilly and Company $LLY
06:22am, Monday, 19'th Jan 2026
Formidable Asset Management LLC grew its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 16.1% during the undefined quarter, according to the company in its most recent 13F filing with the
High Net Worth Advisory Group LLC Cuts Position in Eli Lilly and Company $LLY
05:48am, Monday, 19'th Jan 2026
High Net Worth Advisory Group LLC reduced its position in shares of Eli Lilly and Company (NYSE: LLY) by 36.4% in the undefined quarter, according to the company in its most recent disclosure with the
